Biogen Inc. buy matumba
Start price
07.12.11
/
50%
€83.50
Target price
10.05.12
€102.75
Performance (%)
23.28%
End price
10.05.12
€102.94
Summary
This prediction ended on 10.05.12 with a price of €102.94. The prediction had a final performance of 23.28%. matumba has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biogen Inc. | 11.703% | 11.703% | -27.082% | -9.463% |
iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
Comments by matumba for this prediction
In the thread Biogen Inc. diskutieren
38% Gewinnsteigerung
38% Gewinnsteigerung im 3. Quartal, der älteste Biotechunternehmer läßt die Mitbewerber alt aussehen.
(Zielkurs erreicht)